Pfizer plan to sell its Haleon stake is not surprise: Consumer health company Finance chief Ruchika Sharma4 May 2023 1:30 PM ISTHestler said Pfizer has long been clear about its intention to sell off the stake, suggesting that the reason the potential of the selloff has gained...
Pfizer, Astellas Pharma' Xtandi combo therapy cuts risk of metastasis, death by 58 percent in prostate cancer Ruchika Sharma2 May 2023 12:30 PM ISTXTANDI (enzalutamide) is an androgen receptor signaling inhibitor.
BioNTech , Pfizer propose EU pays half for each cancelled COVID dose: Report Ruchika Sharma1 May 2023 2:15 PM ISTBengaluru: Pfizer Inc and BioNTech's new proposal to the European Union, amid a glut of COVID-19 shots, includes a provision for member states to pay...
Pfizer gets USFDA approval for 20-valent Pneumococcal Conjugate Vaccine PREVNAR 20 for infants, children Ruchika Sharma28 April 2023 11:43 AM ISTPREVNAR 20 builds on Pfizer's approved PREVNAR 13 vaccine, and includes seven additional serotypes (8, 10A, 11A, 12F, 15B, 22F and 33F) shown to be...
Pfizer signs strategic cooperation pact with Sinopharm Ruchika Sharma16 April 2023 9:00 AM ISTUnited States: Pfizer said on Thursday it has signed a strategic cooperation agreement with China's Sinopharm Group, and plans to seek approval to...
Pfizer RSV vaccine 82 percent effective in severe infection in infants: Data Ruchika Sharma7 April 2023 12:30 PM ISTFDA approval could make Pfizer's shot the first maternal vaccine available to prevent the disease in infants.
Pfizer, BioNTech dragged to Court over COVID vaccine patent infringement once again Ruchika Sharma6 April 2023 1:30 PM ISTUS: Arbutus Biopharma on Tuesday sued U.S. drugmaker Pfizer Inc. and its German partner BioNTech SE in a New Jersey district court, claiming...
USFDA accepts Pfizer supplemental new drug applications for BRAFTOVI plus MEKTOVI Ruchika Sharma5 April 2023 12:00 PM ISTNew York: Pfizer Inc. has announced that the U.S. Food and Drug Administration (FDA) has accepted for review the Supplemental New Drug...
XTANDI plus Leuprolide improves Metastasis-Free survival in men with non-metastatic prostate cancer: Pfizer Ruchika Sharma20 March 2023 11:50 AM ISTXTANDI (enzalutamide) is an androgen receptor signaling inhibitor.
Pfizer to replace migraine drug Nurtec ODT packaging over child safety concerns Ruchika Sharma18 March 2023 11:00 AM ISTAs an interim measure, the company has instructed pharmacists to place the drug packet in a child-resistant vial before dispensing it to patients.
Pfizer gets USFDA emergency use nod for Omicron BA.4/BA.5-adapted bivalent COVID booster in children under 5 years Ruchika Sharma15 March 2023 12:15 PM ISTThe Pfizer-BioNTech COVID-19 Vaccines (COMIRNATY) are based on BioNTech's proprietary mRNA technology and were developed by both BioNTech and Pfizer.
Pfizer to acquire Seagen for USD 43 billion Ruchika Sharma14 March 2023 12:00 PM ISTThe proposed acquisition is also expected to enable for combination potential across both the Seagen and Pfizer pipelines and will leverage Pfizer's...
